We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Fastenal
FAST
$56.7B
| $30.2M | 0.02% |
628,100
+496,152
| +376% | +$22.5M |
|
552
Devon Energy
DVN
$53.2B
| $30M | 0.02% |
726,601
+24,264
| +3% | +$1.12M |
|
553
West Pharmaceutical
WST
$23.8B
| $30M | 0.02% |
83,578
+82,005
| +5,213% | +$25.1M |
|
554
GXO Logistics
GXO
$5.36B
| $29.9M | 0.02% |
590,441
+6,668
| +1% | +$345K |
|
|
TMHC
555
DELISTED
Taylor Morrison
TMHC
| $29.9M | 0.02% |
416,989
+403,290
| +2,944% | +$25.6M |
|
556
Bunge Global
BG
$23.8B
| $29.7M | 0.02% |
278,201
-54,439
| -16% | -$6.69M |
|
557
iShares MSCI Brazil ETF
EWZ
$8.79B
| $29.7M | 0.02% |
860,254
+845,554
| +5,752% | +$31.6M |
|
558
XPO
XPO
$22.3B
| $29.6M | 0.02% |
144,247
+134,237
| +1,341% | +$28.4M |
|
559
Huntington Ingalls Industries
HII
$11.3B
| $29.5M | 0.02% |
105,272
-193,968
| -65% | -$64.8M |
|
560
Dr. Reddy's Laboratories
RDY
$9.9B
| $29.3M | 0.02% |
2,025,356
-638,950
| -24% | -$8.62M |
|
561
Home Depot
HD
$313B
| $29.3M | 0.02% |
82,960
-199,976
| -71% | -$65.1M |
|
562
Primoris Services
PRIM
$4.06B
| $29.2M | 0.02% |
294,605
+285,095
| +2,998% | +$37.5M |
|
563
Vita Coco
COCO
$3.08B
| $29.1M | 0.02% |
439,293
-814,647
| -65% | -$55M |
|
564
Lightwave Logic
LWLG
$863M
| $28.9M | 0.02% |
3,057,193
-2,846,651
| -48% | -$33.3M |
|
|
CPRX
565
DELISTED
Catalyst Pharmaceutical
CPRX
| $28.7M | 0.02% |
911,700
+709,885
| +352% | +$21M |
|
566
Penumbra
PEN
$12.6B
| $28.6M | 0.02% |
90,520
+54,240
| +150% | +$17.6M |
|
567
Ulta Beauty
ULTA
$23.5B
| $28.5M | 0.02% |
63,165
+62,680
| +12,924% | +$31.8M |
|
568
CALL
Palo Alto Networks
PANW
$275B
| $28.5M | 0.02% |
+83,500
| New | +$19.1M |
|
|
ECO
569
Okeanis Eco Tankers
ECO
$2.73B
| $28.3M | 0.02% |
565,642
+73,624
| +15% | +$3.84M |
|
570
Champion Homes
SKY
$4.59B
| $28.3M | 0.02% |
321,424
-131,088
| -29% | -$10M |
|
571
Sanmina
SANM
$11B
| $28.1M | 0.02% |
111,224
+22,586
| +25% | +$4.95M |
|
572
Ternium
TX
$11.4B
| $28.1M | 0.02% |
658,994
+624,509
| +1,811% | +$28.1M |
|
573
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
| $27.8M | 0.02% |
39,554
-858
| -2% | -$575K |
|
574
Guardant Health
GH
$21.6B
| $27.8M | 0.02% |
+185,150
| New | +$20.1M |
|
575
Brixmor Property Group
BRX
$8.95B
| $27.7M | 0.02% |
878,126
-578,883
| -40% | -$17.7M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.